They showed that IgG levels against the S2 subunit of SARS-CoV-2 were higher in the PCR-positive and COVID-19 viral symptom groups than in the unexposed group (pre-pandemic), with no differences in SIgA/IgA and SIgM/IgM. The gene discussed is CD79A; the disease is COVID-19.